Found: 27
Select item for more details and to access through your institution.
Real-world evaluation of second line chemotherapy for patients with advanced non-small cell lung cancer harboring preexisting interstitial lung disease.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 1, p. 182, doi. 10.1007/s10637-021-01162-x
- By:
- Publication type:
- Article
Real-world assessment of afatinib for patients with EGFR-positive non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 6, p. 1906, doi. 10.1007/s10637-020-00948-9
- By:
- Publication type:
- Article
Impact of neutrophil-to-lymphocyte ratio in patients with EGFR-mutant NSCLC treated with tyrosine kinase inhibitors.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 3, p. 885, doi. 10.1007/s10637-020-00919-0
- By:
- Publication type:
- Article
Effect of gefitinib on warfarin antithrombotic activity.
- Published in:
- International Journal of Clinical Oncology, 2009, v. 14, n. 4, p. 332, doi. 10.1007/s10147-008-0871-2
- By:
- Publication type:
- Article
Angiotensin-converting enzyme inhibition curbs tyrosine nitration of mitochondrial proteins in the renal cortex during the early stage of diabetes mellitus in rats.
- Published in:
- Clinical Science, 2013, v. 124, n. 8, p. 543, doi. 10.1042/CS20120251
- By:
- Publication type:
- Article
In vitro study on effect of bardoxolone methyl on cisplatin-induced cellular senescence in human proximal tubular cells.
- Published in:
- Molecular & Cellular Biochemistry, 2022, v. 477, n. 3, p. 689, doi. 10.1007/s11010-021-04295-y
- By:
- Publication type:
- Article
Genioglossus muscle activity during sniff and reverse sniff in healthy men.
- Published in:
- Experimental Physiology, 2018, v. 103, n. 12, p. 1656, doi. 10.1113/EP086995
- By:
- Publication type:
- Article
Safety and efficacy of carboplatin plus nab-paclitaxel for treating advanced non-small-cell lung cancer with interstitial lung disease.
- Published in:
- Molecular & Clinical Oncology, 2017, v. 7, n. 4, p. 604, doi. 10.3892/mco.2017.1359
- By:
- Publication type:
- Article
Drug Interaction Between Gefitinib and Warfarin.
- Published in:
- Japanese Journal of Clinical Oncology, 2005, v. 35, n. 8, p. 478, doi. 10.1093/jjco/hyi122
- By:
- Publication type:
- Article
Current status and progress of concurrent chemoradiotherapy in patients with locally advanced non‐small cell lung cancer prior to the approval of durvalumab.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 4, p. 1005, doi. 10.1111/1759-7714.13357
- By:
- Publication type:
- Article
Questionnaire survey on patient awareness of invasive rebiopsy in advanced non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 3, p. 501, doi. 10.1111/1759-7714.12964
- By:
- Publication type:
- Article
Phase I trial of irinotecan and amrubicin with granulocyte colony-stimulating factor support in extensive-stage small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1529, doi. 10.1007/s00280-012-1858-2
- By:
- Publication type:
- Article
Phase I and pharmacologic study of irinotecan and amrubicin in advanced non-small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 4, p. 419, doi. 10.1007/s00280-006-0279-5
- By:
- Publication type:
- Article
Phase I and pharmacologic study of irinotecan and amrubicin in advanced non-small cell lung cancer.
- Published in:
- 2007
- By:
- Publication type:
- journal article
A Prospective Observational Study of Osimertinib for Chemo-Naive Elderly Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer.
- Published in:
- Cancer Management & Research, 2021, v. 13, p. 8695, doi. 10.2147/CMAR.S339891
- By:
- Publication type:
- Article
Impact of Amrubicin Monotherapy as Second-Line Chemotherapy on Outcomes in Elderly Patients with Relapsed Extensive-Disease Small-Cell Lung Cancer.
- Published in:
- Cancer Management & Research, 2020, v. 12, p. 4911, doi. 10.2147/CMAR.S255552
- By:
- Publication type:
- Article
Impact of EGFR genotype on the efficacy of osimertinib in EGFR tyrosine kinase inhibitor-resistant patients with non-small cell lung cancer: a prospective observational study.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 4883, doi. 10.2147/CMAR.S207170
- By:
- Publication type:
- Article
Real-world evaluation of carboplatin plus a weekly dose of nab-paclitaxel for patients with advanced non-small-cell lung cancer with interstitial lung disease.
- Published in:
- Cancer Management & Research, 2018, v. 10, p. 7013, doi. 10.2147/CMAR.S189556
- By:
- Publication type:
- Article
Prognostic significance of the 8th edition of the TNM classification for patients with extensive disease small cell lung cancer.
- Published in:
- Cancer Management & Research, 2018, v. 10, p. 6039, doi. 10.2147/CMAR.S181789
- By:
- Publication type:
- Article
The Glasgow Prognostic Score Predicts Survival in Patients with Advanced Non-Small Cell Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations Who Are Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors.
- Published in:
- Oncology, 2023, v. 101, n. 11, p. 685, doi. 10.1159/000530809
- By:
- Publication type:
- Article
The Glasgow Prognostic Score Predicts Outcomes of Pembrolizumab or Atezolizumab Monotherapy in Patients with Pretreated Non-Small Cell Lung Cancer.
- Published in:
- Oncology, 2023, v. 101, n. 1, p. 69, doi. 10.1159/000526964
- By:
- Publication type:
- Article
Smoking History as a Predictor of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non-Small Cell Lung Cancer Harboring <bold>EGFR</bold> Mutations.
- Published in:
- Oncology, 2018, v. 95, n. 2, p. 109, doi. 10.1159/000488594
- By:
- Publication type:
- Article
Evaluation of concurrent chemoradiotherapy for locally advanced NSCLC according to EGFR mutation status.
- Published in:
- Oncology Letters, 2017, v. 14, n. 1, p. 885, doi. 10.3892/ol.2017.6231
- By:
- Publication type:
- Article
Correlation between the efficacy of amrubicin and the previous chemotherapy regimen for relapsed small cell lung cancer.
- Published in:
- Oncology Letters, 2017, v. 13, n. 3, p. 1719, doi. 10.3892/ol.2017.5662
- By:
- Publication type:
- Article
A Semiquantitative Computed Tomographic Grading System for Evaluating Therapeutic Response in Pulmonary Alveolar Proteinosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Recovery of respiratory muscle strength, physical function, and dyspnoea after lobectomy in lung cancer patients undergoing pulmonary rehabilitation: A retrospective study.
- Published in:
- European Journal of Cancer Care, 2022, v. 31, n. 6, p. 1, doi. 10.1111/ecc.13663
- By:
- Publication type:
- Article
Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer.
- Published in:
- PLoS ONE, 2019, v. 14, n. 5, p. 1, doi. 10.1371/journal.pone.0214599
- By:
- Publication type:
- Article